Intervention to decrease glyburide use in elderly patients with renal insufficiency

American Journal Geriatric Pharmacotherapy

Volumn 9, Issue 1, 2011, Pages 58-68

  Aspinall, Sherrie L ^a,b,c   Zhao, Xinhua ^a,b   Good, Chester B ^a,b,c,d   Stone, Roslyn A ^b,e   Boresi, Joy ^b   Cox, Sarah ^b   Bartholomew, Chad ^f   Jansen, David ^b   Guterman, Sarah ^b   Patino, Mauricio ^b,g   Rivera Miranda, Giselle ^h   Burlingame, Mark ^b   Frazer, Justin ^b   Sellers, Janelle ^f   Stanard Steele, Valerie ^g   Witt, Lauri ^b   Cunningham, Francesca E ^a  

^a VA Center for Medication Safety   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f VA Nebraska Western Iowa Health Care System   (United States)

^g Bay Pines VA Medical Center   (United States)

^h VA Caribbean Healthcare System Puerto Rico   (Puerto Rico)

Author keywords

diabetes mellitus; elderly; glyburide; outcome assessment; renal insufficiency

Indexed keywords

ACARBOSE; CREATININE; GLIBENCLAMIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE;

AFRICAN AMERICAN; AGE; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY SCORE; CHRONIC LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; ETHNICITY; EUROPEAN AMERICAN; FEMALE; GENDER; GERIATRIC PATIENT; HEALTH CARE PERSONNEL; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY DISEASE; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT COMPLIANCE; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RACE; RISK REDUCTION; SCORING SYSTEM; TREATMENT REFUSAL; TREATMENT WITHDRAWAL; VETERAN;

AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; DRUG SUBSTITUTION; GLYBURIDE; HUMANS; KIDNEY; METABOLIC CLEARANCE RATE; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY;

EID: 79953693263     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2011.02.001     Document Type: Article

References (20)

1. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 1996;44:751-755. (Pubitemid 26238715)
2. van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulphonylureas. J Clin Epidemiol. 1997:50:735-741.
3. Gangji AS, Cukierman T, Gerstein HC, et al. A systematic review and meta-analysis of hypoglycemia and cardiovascular events. A comparison of glyburide with other secretagogues and with insulin. Diabetes Care. 2007;30:389-394. (Pubitemid 46198354)
4. Bolen S, Wilson L, Vassy J, et al. Comparative effectiveness and safety of oral diabetes medications for adults with type 2 diabetes. Comparative Effectiveness Review No. 8 (Prepared by Johns Hopkins Evidence-Based Practice Center under Contract No. 290-02-0018.) Rockville, MD: Agency for Healthcare Research and Quality. July 2007. www.effectivehealthcare.ahrq.gov/reports/final. cfm. Accessed May 12, 2010.
5. Charpentier G, Riveline JP, Varroud-Vial M. Management of drugs affecting blood glucose in diabetic patients with renal failure. Diabetes Metab. 2000;26 (Suppl 4):73-85. (Pubitemid 30618360)
6. Krepinsky J, Ingram AJ, Clase CM. Prolonged sulfonylurea-induced hypoglycemia in diabetic patients with endstage renal disease. Am J Kidney Dis. 2000;35:500-505.
7. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
8. Ginde AA, Blanc PG, Lieberman RM, Carmago CA. Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits. BMC Endocr Disord. 2008;8:4-10.
9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497. (Pubitemid 41127293)
10. Ostini R, Hegney D, Jackson C, et al. Systematic review of interventions to improve prescribing. Ann Pharmacother. 2009;43:502-513.
11. Field TS, Rochon P, Lee M, et al. Computerized clinical decision support during medication ordering for long-term care residents with renal insufficiency. J Am Med Inform Assoc. 2009;16:480-485.
12. Chertow CM, Lee J, Kuperman GJ, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001;286:2839-2844. (Pubitemid 33126926)
13. Roberts GW, Farmer CJ, Cheney PC, et al. Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inform Assoc. 2010;17:308-312.
14. Sellier E, Colombet I, Sabatier B, et al. Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency. J Am Med Inform Assoc. 2009;16:203-210.
15. Jamtvedt G, Young JM, Kristoffersen DT, et al. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database Systematic Rev. 2006;6:CD000259.
16. van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13:138-147. (Pubitemid 43332904)
17. Carroll NV. How effectively do managed care organizations influence prescribing and dispensing decisions? Am J Manag Care. 2002;8:1041-1054. (Pubitemid 36040580)
18. Brooks TC, Burlingame M, Burk M, et al. Travoprost: A prostaglandin analogue for the treatment of glaucoma. Formulary. 2009;44:322-328.
19. Nelson WW, Vermeulen LC, Geurkink EA, et al. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole. Arch Intern Med. 2000;160:2491-2496.
20. Gardner J, Scholes D, Baluch W, et al. Acceptability of a substitution of estrogen replacement therapy to women enrolled in a health maintenance organization. J Women's Health. 1998;7:1027-1031.